InvestorsHub Logo
Post# of 253087
Next 10
Followers 839
Posts 120405
Boards Moderated 18
Alias Born 09/05/2002

Re: DewDiligence post# 186652

Wednesday, 01/28/2015 4:27:41 PM

Wednesday, January 28, 2015 4:27:41 PM

Post# of 253087
NVS will present data from two phase-2 trials of RTH258 vs Lucentis/Eylea at The Macula Society annual meeting Feb 25-28. (Source: NVS 4Q14 CC.)

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.